Formulation and Drug Delivery

Nitric Oxide Nasal Spray for COVID-19 to Be Distributed to India and Other Asia Markets

August 04, 2021

Glenmark Pharmaceuticals has partnered with SaNOtize to manufacture, market, and distribute NONS to India, Singapore, Malaysia, Hong Kong, and more.

Janssen Collaborates with BioMedX in Autoimmunity and Drug Delivery Research

August 04, 2021

BioMed X Institute and Janssen Research & Development to start two new research programs in the field of autoimmune diseases and drug delivery.

FDA Approves AstraZeneca’s Lupus mAb, Saphnelo

August 03, 2021

FDA has approved AstraZeneca’s Saphnelo, a type I interferon receptor antibody for treating systemic lupus erythematosus.

EC Makes Supply Agreement with GSK and Vir Biotechnology for mAb COVID-19 Treatment

August 03, 2021

The European Commission has entered into a supply agreement with GlaxoSmithKline and Vir Biotechnology for up to 220,000 doses of sotrovimab, an investigational mAb for treating COVID-19.

Putting the Patient at the Heart of Dosage Form Design

August 03, 2021

Dosage form priorities are shifting to focus on user-friendliness, leading to greater engagement with outsourcing partners earlier in development timelines.

In-Vivo Demonstration of Enhanced Bioavailability of Acalabrutinib ASD Tablets

August 03, 2021

Amorphous solid dispersions can overcome the pH effect encountered with oral oncology medications.

Designing Incubators for Cell Therapy Manufacturing

August 03, 2021

Controlling conditions and preventing contamination are crucial for cell growth.

Developing the Best Formulation Partnership

August 02, 2021

Collaborative partnerships can foster success in formulation development projects.

FDA Approves GSK’s Treatment for Chronic Rhinosinusitis with Nasal Polyps

August 02, 2021

GSK announced that FDA has approved a new indication for Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5.

Recent Research on Amorphous Solid Dispersions

August 02, 2021

Recent research has highlighted the underlying mechanisms of amorphous solid dispersions and theory behind the formation of drug-rich phases.